Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
5.41
+0.28 (5.46%)
At close: Mar 9, 2026, 4:00 PM EDT
5.42
+0.01 (0.18%)
After-hours: Mar 9, 2026, 4:09 PM EDT
Iovance Biotherapeutics Employees
Iovance Biotherapeutics had 975 employees as of December 31, 2025. The number of employees increased by 137 or 16.35% compared to the previous year.
Employees
975
Change (1Y)
137
Growth (1Y)
16.35%
Revenue / Employee
$270,258
Profits / Employee
-$401,003
Market Cap
2.23B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Zai Lab | 1,869 |
| Ultragenyx Pharmaceutical | 1,371 |
| Ascentage Pharma Group International | 605 |
| Galapagos NV | 558 |
| Ocular Therapeutix | 325 |
| Soleno Therapeutics | 182 |
| Day One Biopharmaceuticals | 178 |
| Stoke Therapeutics | 128 |
IOVA News
- 3 days ago - What's Going On With Iovance Biotherapeutics Stock On Friday? - Benzinga
- 5 days ago - Iovance Biotherapeutics: Short-Term Pain, Long-Term Gain - I'm Still Bullish After All These Years - Seeking Alpha
- 11 days ago - Iovance Biotherapeutics to Present at Upcoming Conferences - GlobeNewsWire
- 12 days ago - Iovance Biotherapeutics: Better Gross Margin And Faster Turnaround Support A Higher Floor (Rating Upgrade) - Seeking Alpha
- 13 days ago - Iovance Biotherapeutics Explodes Over 20% — Early Trial Data Sparks Investor Frenzy - Benzinga
- 13 days ago - Iovance Biotherapeutics, Inc. (IOVA) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 13 days ago - Iovance Announces Positive Results from the First Clinical Trial for TIL Cell Therapy in Soft Tissue Sarcomas - GlobeNewsWire
- 13 days ago - Iovance Biotherapeutics Highlights Strong Fourth Quarter and Full Year 2025 Results, Business Achievements and Corporate Updates - GlobeNewsWire